{"gene":"PJA1","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2002,"finding":"PJA1 (Praja1) is a RING-H2 E3 ubiquitin ligase that binds the necdin homology domain of Dlxin-1 (a MAGE/Necdin family protein) via GST pulldown and co-immunoprecipitation, promotes Dlxin-1 ubiquitination in vivo, and targets it for proteasomal degradation, thereby suppressing Dlx5-dependent transcriptional activity. A RING finger mutant of Praja1 abolished ubiquitination and degradation, confirming the requirement for E3 ligase activity.","method":"GST pulldown, co-immunoprecipitation, overexpression with proteasome inhibitor rescue, RING finger mutagenesis, GAL4-based transcription assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis, in vitro binding, and in vivo ubiquitination assay in single study","pmids":["11959851"],"is_preprint":false},{"year":2002,"finding":"Human PJA1 encodes a 71-kDa RING-H2 finger protein that binds the ubiquitin-conjugating enzyme UbcH5B and displays E2-dependent E3 ubiquitin ligase activity in vitro.","method":"In vitro binding assay, immunoprecipitation, in vitro ubiquitination assay","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — in vitro ubiquitination assay with identified E2, corroborated by binding assay","pmids":["12036302"],"is_preprint":false},{"year":2011,"finding":"PRAJA1 directly ubiquitinates individual PRC2 subunits (EZH2, EED, SUZ12) in a cell-free system, leading to their proteasomal degradation; an inactive RING finger mutant failed to enhance degradation, establishing PRAJA1 as a bona fide E3 for PRC2 subunits.","method":"Cell-free ubiquitination assay, RING finger mutagenesis, proteasome inhibitor rescue, DZNep-induced PRC2 dissociation model","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted ubiquitination with mutagenesis controls","pmids":["21513699"],"is_preprint":false},{"year":2011,"finding":"Protein microarray profiling identified UbcH5 family E2s as optimal partners for Praja1 in vitro, and revealed a broad set of putative Praja1 substrates consistent with its roles in bone development and brain function.","method":"Protein microarray ubiquitination screen, in vitro E2 activity panel","journal":"Cell biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 — proteomic screen, substrates not individually validated","pmids":["21461837"],"is_preprint":false},{"year":2013,"finding":"Praja1 co-localizes with cytoskeletal components and NRAGE in PC12 cells, and its overexpression causes proteasome-dependent reduction of NRAGE protein levels, inhibiting NGF-induced neuronal differentiation and neurite formation.","method":"Co-localization immunofluorescence, overexpression with proteasome inhibitor, stable cell lines, neurite outgrowth assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional phenotype with proteasome rescue, but ubiquitination of NRAGE not directly demonstrated","pmids":["23717400"],"is_preprint":false},{"year":2017,"finding":"In differentiating skeletal muscle cells, p38α kinase phosphorylates EZH2 at threonine 372, which promotes recognition and ubiquitin-mediated proteasomal degradation of EZH2 by the MYOD-induced E3 ligase PJA1 (Praja1). Low PJA1 levels and its cytoplasmic localization in proliferating myoblasts prevent premature EZH2 degradation, and nuclear translocation upon differentiation enables EZH2 targeting, allowing muscle gene expression.","method":"Biochemical co-immunoprecipitation, genetic rescue, phospho-mimetic/phospho-dead mutants, subcellular fractionation, siRNA knockdown, satellite cell differentiation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including phospho-mutants, genetic epistasis, and biochemical interaction in a single well-controlled study","pmids":["28067271"],"is_preprint":false},{"year":2018,"finding":"PJA1 restricts DNA viruses (HBV, HSV-1) and episomal plasmids but not RNA viruses, independent of type I/II interferon pathways. PJA1 physically interacts with the SMC5/6 complex and facilitates its binding to viral and episomal DNAs in the cell nucleus; DNA topoisomerase activity is required for PJA1-mediated silencing.","method":"Co-immunoprecipitation, ChIP, knockdown/overexpression with viral replication assays, topoisomerase inhibitor treatment","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with SMC5/6 and ChIP evidence, multiple functional readouts, single lab","pmids":["30185588"],"is_preprint":false},{"year":2020,"finding":"PJA1 binds to C-terminal fragment (CTF) TDP-43 and the E2-conjugating enzyme UBE2E3 as shown by co-immunoprecipitation, suppresses phosphorylation and cytoplasmic aggregate formation of TDP-43 in neuronal cells in vitro, and reduces phosphorylated TDP-43 aggregates in mouse facial motor neurons in vivo.","method":"Co-immunoprecipitation, adenoviral overexpression, immunofluorescence, in vivo mouse facial motor neuron model","journal":"Neuropathology : official journal of the Japanese Society of Neuropathology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with E2 and substrate plus in vivo functional evidence, single lab","pmids":["32686212"],"is_preprint":false},{"year":2020,"finding":"PJA1 promotes ubiquitination and proteasomal degradation of phosphorylated SMAD3 in HCC cells, impairing the SMAD3/β2SP tumor-suppressing TGFβ pathway; an inactive RING finger mutant (RTA405-targeted) failed to enhance SMAD3 degradation.","method":"Ubiquitination assay, co-immunoprecipitation, RING finger inhibitor (RTA405), knockdown/overexpression, xenograft tumor model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 — ubiquitination assay, functional rescue in vivo, pharmacological inhibition, multiple orthogonal methods","pmids":["32127355"],"is_preprint":false},{"year":2020,"finding":"1-Stearoyl-2-docosahexaenoyl (18:0/22:6)-phosphatidic acid (PA), generated by DGKδ, selectively binds to Praja1 and enhances its E3 ubiquitin ligase activity, providing a lipid-based activation mechanism for Praja1-mediated ubiquitination and degradation of SERT in the brain.","method":"Lipid-protein binding assay, DGKδ-knockout mouse brain lipidomics, E3 activity assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct lipid binding and activity assay with knockout mouse model, single lab","pmids":["32134507"],"is_preprint":false},{"year":2020,"finding":"Mass spectrometry revealed that HMGA2 interacts with PJA1 in the nuclei of HCC cells, and this interaction is enhanced by TGFβ treatment, suggesting PJA1 may regulate HMGA2 through ubiquitination in the context of altered TGFβ signaling.","method":"Mass spectrometry, co-localization immunofluorescence","journal":"Genes & cancer","confidence":"Low","confidence_rationale":"Tier 3 — MS interaction identified but ubiquitination not directly demonstrated","pmids":["32577156"],"is_preprint":false},{"year":2021,"finding":"Praja1 interacts with polyglutamine (polyQ) proteins (ataxin-3/huntingtin), enhances their ubiquitin-mediated degradation, reduces aggregate formation in neuronal cells, and suppresses polyQ toxicity in yeast and in a Drosophila SCA3 model.","method":"Co-immunoprecipitation, degradation assay, aggregate quantification, yeast toxicity assay, Drosophila eye degeneration model","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal systems including in vivo Drosophila model, single lab","pmids":["34161122"],"is_preprint":false},{"year":2021,"finding":"PJA1 promotes ubiquitin-mediated degradation of FOXR2 in lung adenocarcinoma cells, inhibiting invasion and inducing apoptosis through inactivation of the Wnt/β-catenin signaling pathway.","method":"Ubiquitination assay, overexpression/knockdown, invasion assay, apoptosis assay, Wnt/β-catenin reporter","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — ubiquitination shown with pathway readout, single lab","pmids":["33839405"],"is_preprint":false},{"year":2022,"finding":"PJA1 binds to and suppresses aggregate formation of multiple neurodegenerative disease-related proteins including FUS, SOD1, α-synuclein, ataxin-3, and huntingtin polyQ in neuronal cultures, as demonstrated by co-immunoprecipitation; Parkin, RNF112, and RNF220, though also binding TDP-43, lacked this broad suppressive activity.","method":"Co-immunoprecipitation, adenoviral expression, aggregate quantification in cultured neuronal cells","journal":"Neuropathology : official journal of the Japanese Society of Neuropathology","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP for multiple substrates with functional aggregate suppression, single lab","pmids":["35701899"],"is_preprint":false},{"year":2022,"finding":"The N-terminal region (aa 1–224) of Praja1 binds 18:0/22:6-phosphatidic acid with Lys141 critical for binding, while the C-terminal RING domain (aa 446–615) interacts with DGKδ2 (via its catalytic domain aa 309–466), revealing distinct regulatory and catalytic domains within Praja1 for lipid-mediated activation and E2/substrate recruitment in the DGKδ2-Praja1-SERT complex.","method":"Domain deletion/truncation binding assays, mutagenesis (Lys141), in vitro protein-lipid interaction","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"Medium","confidence_rationale":"Tier 1-2 — mutagenesis and domain mapping with direct binding assays, single lab","pmids":["36528254"],"is_preprint":false},{"year":2022,"finding":"OTUB2 deubiquitylase stabilizes PJA1 protein by removing ubiquitin chains from PJA1, as demonstrated by co-immunoprecipitation and cycloheximide chase assay, with OTUB2 knockdown reducing PJA1 levels and its oncogenic effects on HCC cells rescued by PJA1 overexpression.","method":"Co-immunoprecipitation, cycloheximide chase, overexpression/knockdown rescue experiment","journal":"Cellular and molecular bioengineering","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP and CHX assay demonstrate deubiquitylation-based stabilization with epistasis rescue, single lab","pmids":["35611163"],"is_preprint":false},{"year":2023,"finding":"Astrocytic GPR30 positively regulates PJA1 expression via the CREB signaling pathway; PJA1 binds to Serpina3n (a neuroinflammation marker) in astrocytes and mediates GPR30-dependent regulation of astrocyte phenotype, learning, and memory in female mice.","method":"Conditional knockout, co-immunoprecipitation (PJA1-Serpina3n), astrocyte phenotype assay, behavioral assays","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype, co-IP for substrate, CREB pathway placement","pmids":["37712419"],"is_preprint":false},{"year":2024,"finding":"PJA1 promotes K48-linked ubiquitination of the mitochondrial protein PGAM5 at K88, leading to its proteasomal degradation, which further facilitates DRP1 phosphorylation at S637, reduces mitochondrial ROS production, suppresses GSDME-mediated pyroptosis, and thereby confers docetaxel resistance in nasopharyngeal carcinoma cells.","method":"Ubiquitination assay (K48-linkage specific), site-directed mutagenesis (K88 of PGAM5), PGAM5 knockdown rescue, DRP1 phosphorylation assay, ROS measurement, pyroptosis assay, in vivo xenograft","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — site-specific ubiquitination mutagenesis, pathway epistasis by rescue, multiple orthogonal readouts, in vivo validation","pmids":["38906860"],"is_preprint":false},{"year":2024,"finding":"Nuclear TDP-43 directly binds the promoter of the PJA1 gene in primates (but not rodents) and transcriptionally activates it; TDP-43 knockdown suppresses PJA1 expression in monkey brain, reducing PJA1-mediated neuroprotection, while PJA1 overexpression rescues neuronal cell death caused by TDP-43 loss.","method":"TDP-43 knockdown in monkey and mouse brain, ChIP/promoter analysis, PJA1 overexpression rescue in vivo","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo primate model with ChIP and rescue, but species-specific result limits generalization","pmids":["38194085"],"is_preprint":false},{"year":2025,"finding":"Praja1 ubiquitinates tau protein (both wild-type and P301L) in in vitro and in vivo ubiquitination assays in SH-SY5Y cells, reducing tau levels in an E3 ligase activity-dependent manner; ancestral sequence reconstruction and mutational analysis showed the Praja1-tau interaction evolved specifically in placental mammals after Praja family duplication.","method":"In vitro ubiquitination assay, in vivo ubiquitination assay in SH-SY5Y cells, E3 ligase mutant controls, ancestral sequence reconstruction, mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo ubiquitination assays with activity-dead mutant controls and evolutionary mutagenesis","pmids":["41182881"],"is_preprint":false},{"year":2025,"finding":"LTP induction triggers rapid proteasome-dependent downregulation of PRAJA1 in the CA1 hippocampus; PRAJA1 knockdown in vivo enhances object recognition and spatial memory, reduces spine density and key synaptic proteins, influences E/I balance, and potentiates GABAergic transmission when overexpressed. Spinophilin was identified as a novel PRAJA1 substrate by co-immunoprecipitation.","method":"In vitro electrophysiology (LTP), in vivo PRAJA1 knockdown, behavioral assays, protein biochemistry, co-immunoprecipitation (spinophilin), spine density analysis","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods with defined synaptic phenotypes, but spinophilin ubiquitination not directly demonstrated","pmids":["40243483"],"is_preprint":false}],"current_model":"PJA1 is a brain-enriched RING-H2 E3 ubiquitin ligase that works with UbcH5B/UBE2E3 E2 enzymes to ubiquitinate and target for proteasomal degradation a wide range of substrates—including EZH2 (phospho-T372 downstream of p38α in myogenesis), PRC2 subunits, SMAD3, PGAM5 (K48-linked at K88), Dlxin-1, NRAGE, FOXR2, TDP-43, tau, polyglutamine proteins, and α-synuclein—thereby regulating chromatin repression, TGFβ signaling, mitochondrial dynamics/pyroptosis, synaptic plasticity, and neuronal proteostasis; its activity is further modulated by 18:0/22:6-phosphatidic acid binding to its N-terminal domain (generated by DGKδ) and by OTUB2-mediated deubiquitylation that stabilizes PJA1 itself."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing PJA1 as a functional RING-H2 E3 ubiquitin ligase resolved its molecular activity: it partners with UbcH5B and ubiquitinates the MAGE-family protein Dlxin-1 for proteasomal degradation, suppressing Dlx5-dependent transcription.","evidence":"GST pulldown, co-IP, in vitro ubiquitination with RING mutant controls, GAL4 reporter assay","pmids":["11959851","12036302"],"confidence":"High","gaps":["Physiological context of Dlxin-1 degradation in vivo not established","Broader substrate repertoire unknown"]},{"year":2011,"claim":"Demonstrating that PJA1 directly ubiquitinates PRC2 subunits (EZH2, EED, SUZ12) in a cell-free system extended its substrate range to chromatin regulators, establishing a link between PJA1 and epigenetic gene silencing.","evidence":"Cell-free reconstituted ubiquitination assay with RING mutant controls, proteasome inhibitor rescue, DZNep-induced PRC2 dissociation model","pmids":["21513699"],"confidence":"High","gaps":["Physiological trigger for PRC2 targeting by PJA1 not identified","Selectivity for individual PRC2 subunits versus intact complex unclear"]},{"year":2013,"claim":"PJA1 overexpression caused proteasome-dependent reduction of NRAGE in neuronal PC12 cells, inhibiting NGF-induced differentiation and neurite outgrowth, providing the first functional link between PJA1 and neuronal differentiation.","evidence":"Overexpression with proteasome inhibitor rescue, neurite outgrowth assay in PC12 cells","pmids":["23717400"],"confidence":"Medium","gaps":["Direct ubiquitination of NRAGE by PJA1 not demonstrated","Endogenous PJA1 role in neuronal differentiation not confirmed by loss-of-function"]},{"year":2017,"claim":"Revealing that p38α-mediated phosphorylation of EZH2 at T372 creates a degron recognized by MYOD-induced PJA1 during myogenesis solved how signal-dependent substrate targeting and subcellular redistribution of PJA1 coordinate muscle gene activation.","evidence":"Phospho-mimetic/phospho-dead EZH2 mutants, subcellular fractionation, siRNA knockdown, satellite cell differentiation in vitro and in vivo","pmids":["28067271"],"confidence":"High","gaps":["Whether PJA1 nuclear translocation mechanism involves a specific import signal remains undefined","Contribution of PJA1 to in vivo muscle regeneration beyond satellite cell assays not tested"]},{"year":2018,"claim":"PJA1 was found to restrict DNA viruses (HBV, HSV-1) by facilitating SMC5/6 complex binding to viral episomal DNA in the nucleus, revealing an unexpected role in innate antiviral defense independent of interferon signaling.","evidence":"Co-IP with SMC5/6, ChIP on viral DNA, knockdown/overexpression with viral replication readouts, topoisomerase inhibitor experiments","pmids":["30185588"],"confidence":"Medium","gaps":["Whether PJA1 ubiquitinates SMC5/6 components or acts as a scaffold is unknown","Single-lab finding not independently replicated","In vivo relevance to viral infection not tested"]},{"year":2020,"claim":"Multiple studies simultaneously expanded PJA1's substrate range and regulatory mechanisms: PJA1 ubiquitinates phospho-SMAD3 to suppress TGFβ tumor-suppressor signaling in HCC, clears TDP-43 aggregates in motor neurons via UBE2E3, and is activated by 18:0/22:6-phosphatidic acid generated by DGKδ, establishing lipid-dependent regulation of E3 ligase activity.","evidence":"Ubiquitination assays with RING inhibitor (RTA405), co-IP with UBE2E3 and TDP-43 CTF, lipid-protein binding assays with DGKδ-KO mouse, in vivo mouse facial motor neuron model, HCC xenograft","pmids":["32127355","32686212","32134507"],"confidence":"High","gaps":["Whether PA-mediated activation applies to all substrates or is SERT-specific","Structural basis for PA-induced conformational change unknown","E2 selectivity for different substrates not systematically mapped"]},{"year":2021,"claim":"PJA1 suppressed polyglutamine protein aggregation and toxicity across yeast, Drosophila, and neuronal cell models, broadening its neuroprotective role to polyQ diseases including SCA3 and Huntington's disease.","evidence":"Co-IP, degradation assay, yeast toxicity assay, Drosophila SCA3 eye degeneration model","pmids":["34161122"],"confidence":"Medium","gaps":["Whether PJA1 directly ubiquitinates expanded polyQ proteins or acts indirectly not resolved","Mammalian in vivo efficacy in polyQ disease models not tested"]},{"year":2022,"claim":"Domain mapping revealed that PJA1's N-terminal region (aa 1–224, Lys141-dependent) binds phosphatidic acid while the C-terminal RING domain interacts with DGKδ2, establishing a modular architecture for lipid-regulated ubiquitination; separately, OTUB2 was identified as a deubiquitylase that stabilizes PJA1 itself.","evidence":"Truncation/mutagenesis binding assays for domain mapping; co-IP and cycloheximide chase for OTUB2-PJA1 stabilization with knockdown rescue in HCC","pmids":["36528254","35611163"],"confidence":"Medium","gaps":["Whether OTUB2-mediated stabilization of PJA1 occurs in non-cancer contexts unknown","Full structural model of PJA1 domains unavailable"]},{"year":2023,"claim":"Astrocytic GPR30 was shown to transcriptionally induce PJA1 via CREB, and PJA1 binds Serpina3n in astrocytes to regulate learning and memory in female mice, placing PJA1 within a sex-specific neuroimmune signaling axis.","evidence":"Conditional knockout, co-IP of PJA1-Serpina3n, behavioral assays in female mice","pmids":["37712419"],"confidence":"Medium","gaps":["Whether PJA1 ubiquitinates Serpina3n or acts through a non-degradative mechanism not determined","Sex-specificity mechanism unexplored"]},{"year":2024,"claim":"Identification of PGAM5 K88 as a PJA1-mediated K48-ubiquitination site linked PJA1 to mitochondrial dynamics: PGAM5 degradation promotes DRP1-S637 phosphorylation, reduces mitochondrial ROS, and suppresses GSDME-mediated pyroptosis, conferring docetaxel resistance in nasopharyngeal carcinoma.","evidence":"K48-linkage-specific ubiquitination assay, K88 mutagenesis, DRP1 phosphorylation, ROS measurement, pyroptosis assay, xenograft","pmids":["38906860"],"confidence":"High","gaps":["Upstream signals that activate PJA1 in drug-resistant tumors not identified","Whether PJA1-PGAM5 axis operates in non-cancer mitochondrial biology unknown"]},{"year":2024,"claim":"Discovery that TDP-43 transcriptionally activates PJA1 by directly binding its promoter in primates—but not rodents—established a primate-specific feedforward neuroprotective loop where PJA1 clears TDP-43 aggregates and TDP-43 sustains PJA1 expression.","evidence":"ChIP/promoter analysis, TDP-43 knockdown in monkey and mouse brain, PJA1 overexpression rescue of neuronal death","pmids":["38194085"],"confidence":"Medium","gaps":["Rodent models may not recapitulate this regulatory circuit","Whether this loop is disrupted in ALS/FTD patients not examined"]},{"year":2025,"claim":"PJA1 directly ubiquitinates tau (wild-type and P301L mutant) in reconstituted and cellular assays, and evolutionary analysis showed this interaction arose specifically in placental mammals after Praja gene duplication, placing PJA1 in the context of Alzheimer's-relevant proteostasis.","evidence":"In vitro and in vivo ubiquitination assays in SH-SY5Y cells, E3-dead mutant controls, ancestral sequence reconstruction and mutagenesis","pmids":["41182881"],"confidence":"High","gaps":["In vivo efficacy of PJA1 in reducing tau pathology in animal models not demonstrated","Whether PJA1 targets physiological or only pathological tau forms unclear"]},{"year":2025,"claim":"LTP induction triggers rapid proteasome-dependent degradation of PJA1 in hippocampal CA1, and PJA1 knockdown enhances memory while altering synaptic protein levels and E/I balance, revealing PJA1 as a plasticity brake whose activity-dependent removal enables memory consolidation; spinophilin was identified as a novel interacting substrate.","evidence":"In vitro electrophysiology (LTP), in vivo knockdown, behavioral tests, co-IP with spinophilin, spine density analysis","pmids":["40243483"],"confidence":"Medium","gaps":["Direct ubiquitination of spinophilin not demonstrated","Mechanism of activity-dependent PJA1 degradation unknown","Whether PJA1 removal is necessary or merely permissive for LTP not determined"]},{"year":null,"claim":"Key unresolved questions include the structural basis for PJA1's remarkably broad substrate recognition, the mechanisms governing its subcellular redistribution, and whether its neuroprotective functions can be therapeutically harnessed in neurodegenerative diseases.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of PJA1 or PJA1-substrate complex available","No substrate-binding domain outside the RING has been structurally defined","In vivo validation of PJA1-mediated neuroprotection in mammalian neurodegenerative disease models is lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,5,8,17,19]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,2,8,17,19]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[9,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,6,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,5,8,17,19]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[2,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,16,17]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[7,13,18,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[17]}],"complexes":[],"partners":["UBE2E3","EZH2","SMAD3","PGAM5","TARDBP","MAPT","OTUB2","DGKΔ"],"other_free_text":[]},"mechanistic_narrative":"PJA1 (Praja1) is a RING-H2 E3 ubiquitin ligase that ubiquitinates a remarkably broad spectrum of substrates to regulate chromatin repression, TGFβ signaling, mitochondrial dynamics, neuronal proteostasis, and synaptic plasticity. It partners with UbcH5/UBE2E3 E2-conjugating enzymes to catalyze K48-linked ubiquitination and proteasomal degradation of substrates including EZH2 and other PRC2 subunits, phosphorylated SMAD3, PGAM5, Dlxin-1, FOXR2, TDP-43 aggregates, tau, polyglutamine-expanded proteins, and α-synuclein [PMID:11959851, PMID:21513699, PMID:32127355, PMID:38906860, PMID:41182881, PMID:35701899]. Its activity is modulated by 18:0/22:6-phosphatidic acid binding to the N-terminal domain (Lys141-dependent, generated by DGKδ), by OTUB2-mediated deubiquitylation that stabilizes PJA1 itself, and by signal-dependent nuclear translocation during skeletal muscle differentiation where p38α-phosphorylated EZH2 becomes a substrate [PMID:32134507, PMID:36528254, PMID:35611163, PMID:28067271]. In the brain, PJA1 suppresses aggregation of multiple neurodegenerative disease-associated proteins, is transcriptionally activated by TDP-43 in primates, and is rapidly downregulated following LTP induction in hippocampal CA1, where it regulates synaptic protein levels, spine density, and excitatory/inhibitory balance [PMID:35701899, PMID:38194085, PMID:40243483]."},"prefetch_data":{"uniprot":{"accession":"Q8NG27","full_name":"E3 ubiquitin-protein ligase Praja-1","aliases":["RING finger protein 70","RING-type E3 ubiquitin transferase Praja-1"],"length_aa":643,"mass_kda":71.0,"function":"Has E2-dependent E3 ubiquitin-protein ligase activity. Ubiquitinates MAGED1 antigen leading to its subsequent degradation by proteasome (By similarity). May be involved in protein sorting","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q8NG27/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PJA1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PJA1","total_profiled":1310},"omim":[{"mim_id":"304110","title":"CRANIOFRONTONASAL SYNDROME; CFNS","url":"https://www.omim.org/entry/304110"},{"mim_id":"300420","title":"PRAJA RING FINGER UBIQUITIN LIGASE 1; PJA1","url":"https://www.omim.org/entry/300420"},{"mim_id":"300035","title":"EPHRIN B1; EFNB1","url":"https://www.omim.org/entry/300035"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"epididymis","ntpm":151.0}],"url":"https://www.proteinatlas.org/search/PJA1"},"hgnc":{"alias_symbol":["FLJ11830","RNF70","PRAJA1"],"prev_symbol":[]},"alphafold":{"accession":"Q8NG27","domains":[{"cath_id":"3.30.40.10","chopping":"568-643","consensus_level":"medium","plddt":83.8074,"start":568,"end":643},{"cath_id":"1.20.5","chopping":"532-565","consensus_level":"medium","plddt":82.5459,"start":532,"end":565}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NG27","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NG27-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NG27-F1-predicted_aligned_error_v6.png","plddt_mean":50.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PJA1","jax_strain_url":"https://www.jax.org/strain/search?query=PJA1"},"sequence":{"accession":"Q8NG27","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NG27.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NG27/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NG27"}},"corpus_meta":[{"pmid":"11959851","id":"PMC_11959851","title":"A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11959851","citation_count":93,"is_preprint":false},{"pmid":"12036302","id":"PMC_12036302","title":"PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12036302","citation_count":51,"is_preprint":false},{"pmid":"28067271","id":"PMC_28067271","title":"Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38α activation.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28067271","citation_count":46,"is_preprint":false},{"pmid":"9393880","id":"PMC_9393880","title":"Praja1, a novel gene encoding a RING-H2 motif in mouse development.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9393880","citation_count":44,"is_preprint":false},{"pmid":"21513699","id":"PMC_21513699","title":"PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21513699","citation_count":44,"is_preprint":false},{"pmid":"17941886","id":"PMC_17941886","title":"Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome.","date":"2007","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17941886","citation_count":36,"is_preprint":false},{"pmid":"30185588","id":"PMC_30185588","title":"PJA1 Coordinates with the SMC5/6 Complex To Restrict DNA Viruses and Episomal Genes in an Interferon-Independent Manner.","date":"2018","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/30185588","citation_count":32,"is_preprint":false},{"pmid":"32686212","id":"PMC_32686212","title":"Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.","date":"2020","source":"Neuropathology : official journal of the Japanese Society of Neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/32686212","citation_count":30,"is_preprint":false},{"pmid":"32134507","id":"PMC_32134507","title":"1-Stearoyl-2-docosahexaenoyl-phosphatidic acid interacts with and activates Praja-1, the E3 ubiquitin ligase acting on the serotonin transporter in the brain.","date":"2020","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/32134507","citation_count":26,"is_preprint":false},{"pmid":"32530565","id":"PMC_32530565","title":"A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders.","date":"2020","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32530565","citation_count":23,"is_preprint":false},{"pmid":"32127355","id":"PMC_32127355","title":"Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32127355","citation_count":22,"is_preprint":false},{"pmid":"38906860","id":"PMC_38906860","title":"PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38906860","citation_count":19,"is_preprint":false},{"pmid":"34161122","id":"PMC_34161122","title":"Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.","date":"2021","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/34161122","citation_count":15,"is_preprint":false},{"pmid":"23717400","id":"PMC_23717400","title":"The ubiquitin ligase Praja1 reduces NRAGE expression and inhibits neuronal differentiation of PC12 cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23717400","citation_count":15,"is_preprint":false},{"pmid":"35701899","id":"PMC_35701899","title":"Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation.","date":"2022","source":"Neuropathology : official journal of the Japanese Society of Neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/35701899","citation_count":13,"is_preprint":false},{"pmid":"37712419","id":"PMC_37712419","title":"PJA1 mediates the effects of astrocytic GPR30 on learning and memory in female mice.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/37712419","citation_count":12,"is_preprint":false},{"pmid":"33457451","id":"PMC_33457451","title":"Dysregulated PJA1-TGF-β signaling in cancer stem cell-associated liver cancers.","date":"2020","source":"Oncoscience","url":"https://pubmed.ncbi.nlm.nih.gov/33457451","citation_count":12,"is_preprint":false},{"pmid":"32577156","id":"PMC_32577156","title":"Alterations in TGF-β signaling leads to high HMGA2 levels potentially through modulation of PJA1/SMAD3 in HCC cells.","date":"2020","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32577156","citation_count":12,"is_preprint":false},{"pmid":"21461837","id":"PMC_21461837","title":"Protein microarrays for the identification of praja1 e3 ubiquitin ligase substrates.","date":"2011","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/21461837","citation_count":10,"is_preprint":false},{"pmid":"33839405","id":"PMC_33839405","title":"E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33839405","citation_count":10,"is_preprint":false},{"pmid":"35611163","id":"PMC_35611163","title":"OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation.","date":"2022","source":"Cellular and molecular bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/35611163","citation_count":9,"is_preprint":false},{"pmid":"36528254","id":"PMC_36528254","title":"Distinct regions of Praja-1 E3 ubiquitin-protein ligase selectively bind to docosahexaenoic acid-containing phosphatidic acid and diacylglycerol kinase δ.","date":"2022","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/36528254","citation_count":5,"is_preprint":false},{"pmid":"41182881","id":"PMC_41182881","title":"E3 ligase Praja1 mediates ubiquitination and degradation of microtubule-associated protein tau.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41182881","citation_count":3,"is_preprint":false},{"pmid":"40243483","id":"PMC_40243483","title":"The E3 Ubiquitin Ligase PRAJA1: A Key Regulator of Synaptic Dynamics and Memory Processes with Implications for Alzheimer's Disease.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40243483","citation_count":3,"is_preprint":false},{"pmid":"38194085","id":"PMC_38194085","title":"Loss of TDP-43 mediates severe neurotoxicity by suppressing PJA1 gene transcription in the monkey brain.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38194085","citation_count":1,"is_preprint":false},{"pmid":"41466523","id":"PMC_41466523","title":"Praja1 E3 ubiquitin ligase and the role it plays in neurodegeneration.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41466523","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14638,"output_tokens":5120,"usd":0.060357},"stage2":{"model":"claude-opus-4-6","input_tokens":8698,"output_tokens":3892,"usd":0.211185},"total_usd":0.271542,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PJA1 (Praja1) is a RING-H2 E3 ubiquitin ligase that binds the necdin homology domain of Dlxin-1 (a MAGE/Necdin family protein) via GST pulldown and co-immunoprecipitation, promotes Dlxin-1 ubiquitination in vivo, and targets it for proteasomal degradation, thereby suppressing Dlx5-dependent transcriptional activity. A RING finger mutant of Praja1 abolished ubiquitination and degradation, confirming the requirement for E3 ligase activity.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, overexpression with proteasome inhibitor rescue, RING finger mutagenesis, GAL4-based transcription assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis, in vitro binding, and in vivo ubiquitination assay in single study\",\n      \"pmids\": [\"11959851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human PJA1 encodes a 71-kDa RING-H2 finger protein that binds the ubiquitin-conjugating enzyme UbcH5B and displays E2-dependent E3 ubiquitin ligase activity in vitro.\",\n      \"method\": \"In vitro binding assay, immunoprecipitation, in vitro ubiquitination assay\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro ubiquitination assay with identified E2, corroborated by binding assay\",\n      \"pmids\": [\"12036302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PRAJA1 directly ubiquitinates individual PRC2 subunits (EZH2, EED, SUZ12) in a cell-free system, leading to their proteasomal degradation; an inactive RING finger mutant failed to enhance degradation, establishing PRAJA1 as a bona fide E3 for PRC2 subunits.\",\n      \"method\": \"Cell-free ubiquitination assay, RING finger mutagenesis, proteasome inhibitor rescue, DZNep-induced PRC2 dissociation model\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted ubiquitination with mutagenesis controls\",\n      \"pmids\": [\"21513699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Protein microarray profiling identified UbcH5 family E2s as optimal partners for Praja1 in vitro, and revealed a broad set of putative Praja1 substrates consistent with its roles in bone development and brain function.\",\n      \"method\": \"Protein microarray ubiquitination screen, in vitro E2 activity panel\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — proteomic screen, substrates not individually validated\",\n      \"pmids\": [\"21461837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Praja1 co-localizes with cytoskeletal components and NRAGE in PC12 cells, and its overexpression causes proteasome-dependent reduction of NRAGE protein levels, inhibiting NGF-induced neuronal differentiation and neurite formation.\",\n      \"method\": \"Co-localization immunofluorescence, overexpression with proteasome inhibitor, stable cell lines, neurite outgrowth assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional phenotype with proteasome rescue, but ubiquitination of NRAGE not directly demonstrated\",\n      \"pmids\": [\"23717400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In differentiating skeletal muscle cells, p38α kinase phosphorylates EZH2 at threonine 372, which promotes recognition and ubiquitin-mediated proteasomal degradation of EZH2 by the MYOD-induced E3 ligase PJA1 (Praja1). Low PJA1 levels and its cytoplasmic localization in proliferating myoblasts prevent premature EZH2 degradation, and nuclear translocation upon differentiation enables EZH2 targeting, allowing muscle gene expression.\",\n      \"method\": \"Biochemical co-immunoprecipitation, genetic rescue, phospho-mimetic/phospho-dead mutants, subcellular fractionation, siRNA knockdown, satellite cell differentiation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including phospho-mutants, genetic epistasis, and biochemical interaction in a single well-controlled study\",\n      \"pmids\": [\"28067271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PJA1 restricts DNA viruses (HBV, HSV-1) and episomal plasmids but not RNA viruses, independent of type I/II interferon pathways. PJA1 physically interacts with the SMC5/6 complex and facilitates its binding to viral and episomal DNAs in the cell nucleus; DNA topoisomerase activity is required for PJA1-mediated silencing.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, knockdown/overexpression with viral replication assays, topoisomerase inhibitor treatment\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with SMC5/6 and ChIP evidence, multiple functional readouts, single lab\",\n      \"pmids\": [\"30185588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PJA1 binds to C-terminal fragment (CTF) TDP-43 and the E2-conjugating enzyme UBE2E3 as shown by co-immunoprecipitation, suppresses phosphorylation and cytoplasmic aggregate formation of TDP-43 in neuronal cells in vitro, and reduces phosphorylated TDP-43 aggregates in mouse facial motor neurons in vivo.\",\n      \"method\": \"Co-immunoprecipitation, adenoviral overexpression, immunofluorescence, in vivo mouse facial motor neuron model\",\n      \"journal\": \"Neuropathology : official journal of the Japanese Society of Neuropathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with E2 and substrate plus in vivo functional evidence, single lab\",\n      \"pmids\": [\"32686212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PJA1 promotes ubiquitination and proteasomal degradation of phosphorylated SMAD3 in HCC cells, impairing the SMAD3/β2SP tumor-suppressing TGFβ pathway; an inactive RING finger mutant (RTA405-targeted) failed to enhance SMAD3 degradation.\",\n      \"method\": \"Ubiquitination assay, co-immunoprecipitation, RING finger inhibitor (RTA405), knockdown/overexpression, xenograft tumor model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ubiquitination assay, functional rescue in vivo, pharmacological inhibition, multiple orthogonal methods\",\n      \"pmids\": [\"32127355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"1-Stearoyl-2-docosahexaenoyl (18:0/22:6)-phosphatidic acid (PA), generated by DGKδ, selectively binds to Praja1 and enhances its E3 ubiquitin ligase activity, providing a lipid-based activation mechanism for Praja1-mediated ubiquitination and degradation of SERT in the brain.\",\n      \"method\": \"Lipid-protein binding assay, DGKδ-knockout mouse brain lipidomics, E3 activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct lipid binding and activity assay with knockout mouse model, single lab\",\n      \"pmids\": [\"32134507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mass spectrometry revealed that HMGA2 interacts with PJA1 in the nuclei of HCC cells, and this interaction is enhanced by TGFβ treatment, suggesting PJA1 may regulate HMGA2 through ubiquitination in the context of altered TGFβ signaling.\",\n      \"method\": \"Mass spectrometry, co-localization immunofluorescence\",\n      \"journal\": \"Genes & cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — MS interaction identified but ubiquitination not directly demonstrated\",\n      \"pmids\": [\"32577156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Praja1 interacts with polyglutamine (polyQ) proteins (ataxin-3/huntingtin), enhances their ubiquitin-mediated degradation, reduces aggregate formation in neuronal cells, and suppresses polyQ toxicity in yeast and in a Drosophila SCA3 model.\",\n      \"method\": \"Co-immunoprecipitation, degradation assay, aggregate quantification, yeast toxicity assay, Drosophila eye degeneration model\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal systems including in vivo Drosophila model, single lab\",\n      \"pmids\": [\"34161122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PJA1 promotes ubiquitin-mediated degradation of FOXR2 in lung adenocarcinoma cells, inhibiting invasion and inducing apoptosis through inactivation of the Wnt/β-catenin signaling pathway.\",\n      \"method\": \"Ubiquitination assay, overexpression/knockdown, invasion assay, apoptosis assay, Wnt/β-catenin reporter\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ubiquitination shown with pathway readout, single lab\",\n      \"pmids\": [\"33839405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PJA1 binds to and suppresses aggregate formation of multiple neurodegenerative disease-related proteins including FUS, SOD1, α-synuclein, ataxin-3, and huntingtin polyQ in neuronal cultures, as demonstrated by co-immunoprecipitation; Parkin, RNF112, and RNF220, though also binding TDP-43, lacked this broad suppressive activity.\",\n      \"method\": \"Co-immunoprecipitation, adenoviral expression, aggregate quantification in cultured neuronal cells\",\n      \"journal\": \"Neuropathology : official journal of the Japanese Society of Neuropathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP for multiple substrates with functional aggregate suppression, single lab\",\n      \"pmids\": [\"35701899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The N-terminal region (aa 1–224) of Praja1 binds 18:0/22:6-phosphatidic acid with Lys141 critical for binding, while the C-terminal RING domain (aa 446–615) interacts with DGKδ2 (via its catalytic domain aa 309–466), revealing distinct regulatory and catalytic domains within Praja1 for lipid-mediated activation and E2/substrate recruitment in the DGKδ2-Praja1-SERT complex.\",\n      \"method\": \"Domain deletion/truncation binding assays, mutagenesis (Lys141), in vitro protein-lipid interaction\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis and domain mapping with direct binding assays, single lab\",\n      \"pmids\": [\"36528254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"OTUB2 deubiquitylase stabilizes PJA1 protein by removing ubiquitin chains from PJA1, as demonstrated by co-immunoprecipitation and cycloheximide chase assay, with OTUB2 knockdown reducing PJA1 levels and its oncogenic effects on HCC cells rescued by PJA1 overexpression.\",\n      \"method\": \"Co-immunoprecipitation, cycloheximide chase, overexpression/knockdown rescue experiment\",\n      \"journal\": \"Cellular and molecular bioengineering\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP and CHX assay demonstrate deubiquitylation-based stabilization with epistasis rescue, single lab\",\n      \"pmids\": [\"35611163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Astrocytic GPR30 positively regulates PJA1 expression via the CREB signaling pathway; PJA1 binds to Serpina3n (a neuroinflammation marker) in astrocytes and mediates GPR30-dependent regulation of astrocyte phenotype, learning, and memory in female mice.\",\n      \"method\": \"Conditional knockout, co-immunoprecipitation (PJA1-Serpina3n), astrocyte phenotype assay, behavioral assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype, co-IP for substrate, CREB pathway placement\",\n      \"pmids\": [\"37712419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PJA1 promotes K48-linked ubiquitination of the mitochondrial protein PGAM5 at K88, leading to its proteasomal degradation, which further facilitates DRP1 phosphorylation at S637, reduces mitochondrial ROS production, suppresses GSDME-mediated pyroptosis, and thereby confers docetaxel resistance in nasopharyngeal carcinoma cells.\",\n      \"method\": \"Ubiquitination assay (K48-linkage specific), site-directed mutagenesis (K88 of PGAM5), PGAM5 knockdown rescue, DRP1 phosphorylation assay, ROS measurement, pyroptosis assay, in vivo xenograft\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — site-specific ubiquitination mutagenesis, pathway epistasis by rescue, multiple orthogonal readouts, in vivo validation\",\n      \"pmids\": [\"38906860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nuclear TDP-43 directly binds the promoter of the PJA1 gene in primates (but not rodents) and transcriptionally activates it; TDP-43 knockdown suppresses PJA1 expression in monkey brain, reducing PJA1-mediated neuroprotection, while PJA1 overexpression rescues neuronal cell death caused by TDP-43 loss.\",\n      \"method\": \"TDP-43 knockdown in monkey and mouse brain, ChIP/promoter analysis, PJA1 overexpression rescue in vivo\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo primate model with ChIP and rescue, but species-specific result limits generalization\",\n      \"pmids\": [\"38194085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Praja1 ubiquitinates tau protein (both wild-type and P301L) in in vitro and in vivo ubiquitination assays in SH-SY5Y cells, reducing tau levels in an E3 ligase activity-dependent manner; ancestral sequence reconstruction and mutational analysis showed the Praja1-tau interaction evolved specifically in placental mammals after Praja family duplication.\",\n      \"method\": \"In vitro ubiquitination assay, in vivo ubiquitination assay in SH-SY5Y cells, E3 ligase mutant controls, ancestral sequence reconstruction, mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo ubiquitination assays with activity-dead mutant controls and evolutionary mutagenesis\",\n      \"pmids\": [\"41182881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LTP induction triggers rapid proteasome-dependent downregulation of PRAJA1 in the CA1 hippocampus; PRAJA1 knockdown in vivo enhances object recognition and spatial memory, reduces spine density and key synaptic proteins, influences E/I balance, and potentiates GABAergic transmission when overexpressed. Spinophilin was identified as a novel PRAJA1 substrate by co-immunoprecipitation.\",\n      \"method\": \"In vitro electrophysiology (LTP), in vivo PRAJA1 knockdown, behavioral assays, protein biochemistry, co-immunoprecipitation (spinophilin), spine density analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with defined synaptic phenotypes, but spinophilin ubiquitination not directly demonstrated\",\n      \"pmids\": [\"40243483\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PJA1 is a brain-enriched RING-H2 E3 ubiquitin ligase that works with UbcH5B/UBE2E3 E2 enzymes to ubiquitinate and target for proteasomal degradation a wide range of substrates—including EZH2 (phospho-T372 downstream of p38α in myogenesis), PRC2 subunits, SMAD3, PGAM5 (K48-linked at K88), Dlxin-1, NRAGE, FOXR2, TDP-43, tau, polyglutamine proteins, and α-synuclein—thereby regulating chromatin repression, TGFβ signaling, mitochondrial dynamics/pyroptosis, synaptic plasticity, and neuronal proteostasis; its activity is further modulated by 18:0/22:6-phosphatidic acid binding to its N-terminal domain (generated by DGKδ) and by OTUB2-mediated deubiquitylation that stabilizes PJA1 itself.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PJA1 (Praja1) is a RING-H2 E3 ubiquitin ligase that ubiquitinates a remarkably broad spectrum of substrates to regulate chromatin repression, TGFβ signaling, mitochondrial dynamics, neuronal proteostasis, and synaptic plasticity. It partners with UbcH5/UBE2E3 E2-conjugating enzymes to catalyze K48-linked ubiquitination and proteasomal degradation of substrates including EZH2 and other PRC2 subunits, phosphorylated SMAD3, PGAM5, Dlxin-1, FOXR2, TDP-43 aggregates, tau, polyglutamine-expanded proteins, and α-synuclein [PMID:11959851, PMID:21513699, PMID:32127355, PMID:38906860, PMID:41182881, PMID:35701899]. Its activity is modulated by 18:0/22:6-phosphatidic acid binding to the N-terminal domain (Lys141-dependent, generated by DGKδ), by OTUB2-mediated deubiquitylation that stabilizes PJA1 itself, and by signal-dependent nuclear translocation during skeletal muscle differentiation where p38α-phosphorylated EZH2 becomes a substrate [PMID:32134507, PMID:36528254, PMID:35611163, PMID:28067271]. In the brain, PJA1 suppresses aggregation of multiple neurodegenerative disease-associated proteins, is transcriptionally activated by TDP-43 in primates, and is rapidly downregulated following LTP induction in hippocampal CA1, where it regulates synaptic protein levels, spine density, and excitatory/inhibitory balance [PMID:35701899, PMID:38194085, PMID:40243483].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing PJA1 as a functional RING-H2 E3 ubiquitin ligase resolved its molecular activity: it partners with UbcH5B and ubiquitinates the MAGE-family protein Dlxin-1 for proteasomal degradation, suppressing Dlx5-dependent transcription.\",\n      \"evidence\": \"GST pulldown, co-IP, in vitro ubiquitination with RING mutant controls, GAL4 reporter assay\",\n      \"pmids\": [\"11959851\", \"12036302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of Dlxin-1 degradation in vivo not established\", \"Broader substrate repertoire unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that PJA1 directly ubiquitinates PRC2 subunits (EZH2, EED, SUZ12) in a cell-free system extended its substrate range to chromatin regulators, establishing a link between PJA1 and epigenetic gene silencing.\",\n      \"evidence\": \"Cell-free reconstituted ubiquitination assay with RING mutant controls, proteasome inhibitor rescue, DZNep-induced PRC2 dissociation model\",\n      \"pmids\": [\"21513699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger for PRC2 targeting by PJA1 not identified\", \"Selectivity for individual PRC2 subunits versus intact complex unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"PJA1 overexpression caused proteasome-dependent reduction of NRAGE in neuronal PC12 cells, inhibiting NGF-induced differentiation and neurite outgrowth, providing the first functional link between PJA1 and neuronal differentiation.\",\n      \"evidence\": \"Overexpression with proteasome inhibitor rescue, neurite outgrowth assay in PC12 cells\",\n      \"pmids\": [\"23717400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ubiquitination of NRAGE by PJA1 not demonstrated\", \"Endogenous PJA1 role in neuronal differentiation not confirmed by loss-of-function\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealing that p38α-mediated phosphorylation of EZH2 at T372 creates a degron recognized by MYOD-induced PJA1 during myogenesis solved how signal-dependent substrate targeting and subcellular redistribution of PJA1 coordinate muscle gene activation.\",\n      \"evidence\": \"Phospho-mimetic/phospho-dead EZH2 mutants, subcellular fractionation, siRNA knockdown, satellite cell differentiation in vitro and in vivo\",\n      \"pmids\": [\"28067271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PJA1 nuclear translocation mechanism involves a specific import signal remains undefined\", \"Contribution of PJA1 to in vivo muscle regeneration beyond satellite cell assays not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"PJA1 was found to restrict DNA viruses (HBV, HSV-1) by facilitating SMC5/6 complex binding to viral episomal DNA in the nucleus, revealing an unexpected role in innate antiviral defense independent of interferon signaling.\",\n      \"evidence\": \"Co-IP with SMC5/6, ChIP on viral DNA, knockdown/overexpression with viral replication readouts, topoisomerase inhibitor experiments\",\n      \"pmids\": [\"30185588\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PJA1 ubiquitinates SMC5/6 components or acts as a scaffold is unknown\", \"Single-lab finding not independently replicated\", \"In vivo relevance to viral infection not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Multiple studies simultaneously expanded PJA1's substrate range and regulatory mechanisms: PJA1 ubiquitinates phospho-SMAD3 to suppress TGFβ tumor-suppressor signaling in HCC, clears TDP-43 aggregates in motor neurons via UBE2E3, and is activated by 18:0/22:6-phosphatidic acid generated by DGKδ, establishing lipid-dependent regulation of E3 ligase activity.\",\n      \"evidence\": \"Ubiquitination assays with RING inhibitor (RTA405), co-IP with UBE2E3 and TDP-43 CTF, lipid-protein binding assays with DGKδ-KO mouse, in vivo mouse facial motor neuron model, HCC xenograft\",\n      \"pmids\": [\"32127355\", \"32686212\", \"32134507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PA-mediated activation applies to all substrates or is SERT-specific\", \"Structural basis for PA-induced conformational change unknown\", \"E2 selectivity for different substrates not systematically mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"PJA1 suppressed polyglutamine protein aggregation and toxicity across yeast, Drosophila, and neuronal cell models, broadening its neuroprotective role to polyQ diseases including SCA3 and Huntington's disease.\",\n      \"evidence\": \"Co-IP, degradation assay, yeast toxicity assay, Drosophila SCA3 eye degeneration model\",\n      \"pmids\": [\"34161122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PJA1 directly ubiquitinates expanded polyQ proteins or acts indirectly not resolved\", \"Mammalian in vivo efficacy in polyQ disease models not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Domain mapping revealed that PJA1's N-terminal region (aa 1–224, Lys141-dependent) binds phosphatidic acid while the C-terminal RING domain interacts with DGKδ2, establishing a modular architecture for lipid-regulated ubiquitination; separately, OTUB2 was identified as a deubiquitylase that stabilizes PJA1 itself.\",\n      \"evidence\": \"Truncation/mutagenesis binding assays for domain mapping; co-IP and cycloheximide chase for OTUB2-PJA1 stabilization with knockdown rescue in HCC\",\n      \"pmids\": [\"36528254\", \"35611163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether OTUB2-mediated stabilization of PJA1 occurs in non-cancer contexts unknown\", \"Full structural model of PJA1 domains unavailable\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Astrocytic GPR30 was shown to transcriptionally induce PJA1 via CREB, and PJA1 binds Serpina3n in astrocytes to regulate learning and memory in female mice, placing PJA1 within a sex-specific neuroimmune signaling axis.\",\n      \"evidence\": \"Conditional knockout, co-IP of PJA1-Serpina3n, behavioral assays in female mice\",\n      \"pmids\": [\"37712419\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PJA1 ubiquitinates Serpina3n or acts through a non-degradative mechanism not determined\", \"Sex-specificity mechanism unexplored\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of PGAM5 K88 as a PJA1-mediated K48-ubiquitination site linked PJA1 to mitochondrial dynamics: PGAM5 degradation promotes DRP1-S637 phosphorylation, reduces mitochondrial ROS, and suppresses GSDME-mediated pyroptosis, conferring docetaxel resistance in nasopharyngeal carcinoma.\",\n      \"evidence\": \"K48-linkage-specific ubiquitination assay, K88 mutagenesis, DRP1 phosphorylation, ROS measurement, pyroptosis assay, xenograft\",\n      \"pmids\": [\"38906860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals that activate PJA1 in drug-resistant tumors not identified\", \"Whether PJA1-PGAM5 axis operates in non-cancer mitochondrial biology unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that TDP-43 transcriptionally activates PJA1 by directly binding its promoter in primates—but not rodents—established a primate-specific feedforward neuroprotective loop where PJA1 clears TDP-43 aggregates and TDP-43 sustains PJA1 expression.\",\n      \"evidence\": \"ChIP/promoter analysis, TDP-43 knockdown in monkey and mouse brain, PJA1 overexpression rescue of neuronal death\",\n      \"pmids\": [\"38194085\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Rodent models may not recapitulate this regulatory circuit\", \"Whether this loop is disrupted in ALS/FTD patients not examined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PJA1 directly ubiquitinates tau (wild-type and P301L mutant) in reconstituted and cellular assays, and evolutionary analysis showed this interaction arose specifically in placental mammals after Praja gene duplication, placing PJA1 in the context of Alzheimer's-relevant proteostasis.\",\n      \"evidence\": \"In vitro and in vivo ubiquitination assays in SH-SY5Y cells, E3-dead mutant controls, ancestral sequence reconstruction and mutagenesis\",\n      \"pmids\": [\"41182881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo efficacy of PJA1 in reducing tau pathology in animal models not demonstrated\", \"Whether PJA1 targets physiological or only pathological tau forms unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"LTP induction triggers rapid proteasome-dependent degradation of PJA1 in hippocampal CA1, and PJA1 knockdown enhances memory while altering synaptic protein levels and E/I balance, revealing PJA1 as a plasticity brake whose activity-dependent removal enables memory consolidation; spinophilin was identified as a novel interacting substrate.\",\n      \"evidence\": \"In vitro electrophysiology (LTP), in vivo knockdown, behavioral tests, co-IP with spinophilin, spine density analysis\",\n      \"pmids\": [\"40243483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ubiquitination of spinophilin not demonstrated\", \"Mechanism of activity-dependent PJA1 degradation unknown\", \"Whether PJA1 removal is necessary or merely permissive for LTP not determined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for PJA1's remarkably broad substrate recognition, the mechanisms governing its subcellular redistribution, and whether its neuroprotective functions can be therapeutically harnessed in neurodegenerative diseases.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of PJA1 or PJA1-substrate complex available\", \"No substrate-binding domain outside the RING has been structurally defined\", \"In vivo validation of PJA1-mediated neuroprotection in mammalian neurodegenerative disease models is lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 5, 8, 17, 19]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 2, 8, 17, 19]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [9, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 6, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 5, 8, 17, 19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 16, 17]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 13, 18, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"UBE2E3\",\n      \"EZH2\",\n      \"SMAD3\",\n      \"PGAM5\",\n      \"TARDBP\",\n      \"MAPT\",\n      \"OTUB2\",\n      \"DGKδ\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}